Eisai

Asia, Tokyo, Japan, Tokyo

Description

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Investor Profile

Eisai has made 8 investments, with 1 in the past 12 months and 25% as lead.

Stage Focus

Series A (50%)
Series C (25%)
Series Unknown (13%)
Pre Seed (13%)

Country Focus

United States (38%)
Japan (25%)
Singapore (25%)
Finland (13%)

Industry Focus

Biotechnology
Health Care
Life Science
Therapeutics
Medical
Information And Communications Technology (Ict)
Information Technology
Mobile Apps
Wearables
Artificial Intelligence (Ai)

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eisai frequently co-invest with?

Mitsui & Co

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

Philips

Europe, Noord-Holland, The Netherlands, Amsterdam

Co-Investments: 1

SBI Investment

Asia, Chiba, Japan, Minato

Co-Investments: 1

Capital Medica Ventures

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

Nippon Information Development

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

Mizuho Capital

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

Cyberdyne

Asia, Ibaraki, Japan, Tsukuba

Co-Investments: 1

Bonds Investment Group

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

mixi

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

AAIC Investment

Asia, Central Region, Singapore, Singapore

Co-Investments: 1

Which angels does Eisai often collaborate with?

Wendou Niu

Asia, Singapore

Shared Deals: 1

Raman Singh

Asia, Singapore

Shared Deals: 1

Kuldeep Singh Rajput

North America, Massachusetts, United States, Boston

Shared Deals: 2

Marc Benioff

North America, California, United States, San Francisco

Shared Deals: 1

What are some of recent deals done by Eisai?

Seed Therapeutics

New York, New York, United States

Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.

BiotechnologyMedicalTherapeutics

Series AAug 6, 2024

Amount Raised: $24,000,000

Casma Therapeutics

Cambridge, Massachusetts, United States

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

BiotechnologyHealth CareTherapeutics

Series CNov 15, 2022

Amount Raised: $46,000,000

Neuroglee Therapeutics

Singapore, Central Region, Singapore

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

BiotechnologyLife Science

Series ASep 9, 2021

Amount Raised: $10,000,000

Oura

Oulu, Oulu, Finland

Oura is a health technology company that makes and designs wellness wearable rings to track and improve sleep and performance.

Health CareMobile AppsWearables

Series CMay 4, 2021

Amount Raised: $100,000,000

Allm

Tokyo, Tokyo, Japan

Allm is a medical ICT company develops innovative mHealth solutions transforming the way healthcare providers collaborate.

Health CareInformation and Communications Technology (ICT)Information TechnologyMedical

Series AApr 5, 2021

Amount Raised: $50,819,464

Neuroglee Therapeutics

Singapore, Central Region, Singapore

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

BiotechnologyLife Science

Pre SeedDec 3, 2020

Amount Raised: $2,300,000

Unlearn.AI

San Francisco, California, United States

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

Artificial Intelligence (AI)BioinformaticsClinical TrialsLife Science

Series ANov 5, 2020

Amount Raised: $3,000,000

SymBio Pharmaceuticals

Tokyo, Tokyo, Japan

SymBio Pharmaceuticals develops therapeutic products for cancer, hematology, and autoimmune diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics

Series UnknownDec 11, 2009

Amount Raised: $24,704,501

Eisai

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Eisai frequently co-invest with?

Which angels does Eisai often collaborate with?

What are some of recent deals done by Eisai?

Ready to Raise Capital?

Pages

Free tools